StemCell Institute(JP:7096)
Â¥668.00+25.00 (+3.89%)
JP:7096
StemCell Institute Revenue
Â¥668.00
At close:+25.00 (+3.89%)
Want to see JP:7096 full AI Analyst Report?
StemCell Institute (7096) Revenue
0 Followers
StemCell Institute Revenue
StemCell Institute had a revenue of 667.33M in the quarter ending Mar 31, 2026, with -8.45%. This bring the company's revenue in the last twelve months to 2.81B, Increased 1.03%. In the fiscal year ending Mar 31, 2026, StemCell Institute had annual revenue of 2.81B with 4.93% growth.
- Revenue (ttm)
- 2.81B
- Revenue Growth
- 4.85%
- P/S Ratio
- 2.34
- Revenue/Employee
- JPY 24,028,581
- Employees
- 117
- Market Cap
- JPY 6.59B
Revenue Chart
StemCell Institute Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 2.81B | 132.17M | 4.93% |
| Mar 31, 2025 | 2.68B | 197.98M | 7.98% |
| Mar 31, 2024 | 2.48B | 389.90M | 18.64% |
| Mar 31, 2023 | 2.09B | 309.35M | 17.36% |
| Mar 31, 2022 | 1.78B | 372.43M | 26.42% |
| Mar 31, 2021 | 1.41B | -266.49M | -15.90% |
| Mar 31, 2020 | 1.68B | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.